How Does Your Genetic Make-up (Profile) Influence Your Glaucoma?
Nuclear Genetic and Mitochondrial Influences in Glaucoma
1 other identifier
observational
97
1 country
1
Brief Summary
Glaucoma is a group of diseases in which visual loss occurs because of damage to the optic nerve. Research has shown that certain genes may cause glaucoma in some cases. So far, research has only been able to find the genes responsible for glaucoma in a small percentage of people who have glaucoma. The purpose of this project is to study the genes in patients with and without glaucoma to find additional genes that may be responsible for causing glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2008
CompletedFirst Posted
Study publicly available on registry
February 29, 2008
CompletedStudy Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedNovember 21, 2016
November 1, 2016
1.4 years
February 20, 2008
November 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The investigators will quantify the spectrum of changes in mitochondrial respiration, relative mitochondrial DNA content, and oxidative stress associated with different types of glaucoma.
one blood draw
Study Arms (2)
1
Primary Open Angle Glaucoma (POAG)
2
Controls (Normals, patients without glaucoma)
Eligibility Criteria
glaucoma clinic
You may qualify if:
- yrs
- Caucasian or African American
- Male or female with POAG, PACG, PXFG,
- Normal
You may not qualify if:
- Other ophthamic co-morbidities
- Other ethnic groups
- Unable to understand and give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wills Eyelead
- Jefferson Medical College of Thomas Jefferson Universitycollaborator
- Thomas Jefferson Universitycollaborator
Study Sites (1)
Wills Eye Glaucoma Service
Philadelphia, Pennsylvania, 19107, United States
Related Publications (2)
Abu-Amero KK, Azad TA, Spaeth GL, Myers J, Katz LJ, Moster M, Bosley TM. Unaltered myocilin expression in the blood of primary open angle glaucoma patients. Mol Vis. 2012;18:1004-9. Epub 2012 Apr 21.
PMID: 22550394RESULTAbu-Amero KK, Azad TA, Spaeth GL, Myers J, Katz LJ, Moster M, Bosley TM. Absence of altered expression of optineurin in primary open angle glaucoma patients. Mol Vis. 2012;18:1421-7. Epub 2012 Jun 1.
PMID: 22690120RESULT
Biospecimen
whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George L Spaeth, MD
Wills Eye Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Glaucoma Research Center Wills Eye; Director Medical Research and Education Glaucoma Service Foundation Wills Eye; Esposito Research Professor, Thomas Jefferson University
Study Record Dates
First Submitted
February 20, 2008
First Posted
February 29, 2008
Study Start
March 1, 2008
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
November 21, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will share
Two manuscripts have been written and published.